Results
26,449 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 30 | Van Tuyl ChristopherChief Legal Officer |  IMVTImmunovant, Inc.Open-market sale | SELL | $128K 5,165 sh | Apr 10, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 30 | Van Tuyl ChristopherChief Legal Officer | IMVTImmunovant, Inc. Open-market sale | SELL | $128K 5,165 sh | Apr 10, 2026 |
| 30 | Gloria MelanieChief Operating Officer | IMVTImmunovant, Inc. Open-market sale | SELL | $217K 8,722 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 29 | Li TianminChief Technology Officer |  VIPSVipshop Holdings LtdOpen-market sale | SELL | $193K 2,482 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 29 | Intrator Michael NDirector, CEO and President, 10% Owner |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $654K 7,270 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 29 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $727K 8,080 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 28 | George GregoryDirector, 10% Owner |  MESOMESOBLAST LTDOpen-market purchase | BUY | $143K 10.0K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 28 | George GregoryDirector, 10% Owner | MESOMESOBLAST LTD Open-market purchase | BUY | $72K 5,000 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 28 | Neagle MatthewChief Operating Officer |  PRCHPorch Group, Inc.Open-market sale | SELL | $449K 62.8K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 28 | George GregoryDirector, 10% Owner | MESOMESOBLAST LTD Open-market purchase | BUY | $75K 5,240 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 28 | George GregoryDirector, 10% Owner | MESOMESOBLAST LTD Open-market purchase | BUY | $141K 10.0K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 28 | George GregoryDirector, 10% Owner | MESOMESOBLAST LTD Open-market purchase | BUY | $143K 10.0K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 28 | George GregoryDirector, 10% Owner | MESOMESOBLAST LTD Open-market purchase | BUY | $144K 10.0K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 28 | George GregoryDirector, 10% Owner | MESOMESOBLAST LTD Open-market purchase | BUY | $143K 10.0K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 28 | George GregoryDirector, 10% Owner | MESOMESOBLAST LTD Open-market purchase | BUY | $69K 4,760 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 28 | George GregoryDirector, 10% Owner | MESOMESOBLAST LTD Open-market purchase | BUY | $143K 10.0K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 27 | Stout Jay SChief Technology Officer | IMVTImmunovant, Inc. Open-market sale | SELL | $38K 1,518 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 27 | Gold JudithDirector |  RSIRush Street Interactive, Inc.Open-market sale · 10b5-1 plan | SELL | $39K 1,714 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 26 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $237K 2,600 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $65K 700 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $219K 2,400 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 26 | Lo FrancisChief People Officer |  ADPTAdaptive Biotechnologies CorpOpen-market sale · 10b5-1 plan | SELL | $340K 22.6K sh | Apr 10, 2026 traded Apr 8, 2026 |
| 26 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $55K 600 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 25 | Mindlin Damian MiguelVice President |  PAMPampa Energy Inc.Open-market sale | SELL | $200K 57.5K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 23 | Agrawal NitinChief Financial Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1,288 14 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 23 | Intrator Michael NDirector, CEO and President, 10% Owner | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $9,340 100 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 23 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $9,340 100 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 22 | Billingsley ChesterDirector, Chief Executive Officer, 10% Owner |  MNTRMentor Capital, Inc.Open-market purchase | BUY | $57 950 sh | Apr 10, 2026 traded Apr 10, 2026 |
| 22 | Billingsley ChesterDirector, Chief Executive Officer, 10% Owner | MNTRMentor Capital, Inc. Open-market purchase | BUY | $65.1 1,050 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 22 | Billingsley ChesterDirector, Chief Executive Officer, 10% Owner | MNTRMentor Capital, Inc. Open-market purchase | BUY | $124 2,000 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 22 | Rezvan MitraChief Accounting Officer |  SAILSailPoint, Inc.Open-market sale · 10b5-1 plan | SELL | $21K 1,683 sh | Apr 10, 2026 traded Apr 7, 2026 |
| 22 | Tabak ShawnCHIEF FINANCIAL OFFICER | PRCHPorch Group, Inc. Open-market sale | SELL | $55K 7,734 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 22 | Lennon David JamesDirector, CHIEF EXECUTIVE OFFICER |  WHWKWhitehawk Therapeutics, Inc.Open-market sale | SELL | $49K 14.5K sh | Apr 10, 2026 traded Apr 9, 2026 |
| 19 | Robins Harlan SChief Scientific Officer | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $149K 10.0K sh | Apr 10, 2026 traded Apr 8, 2026 |
| 18 | Edgemond JamesCFO AND TREASURER |  UTHRUNITED THERAPEUTICS CorpOpen-market sale · 10b5-1 plan | SELL | $1.02M 1,756 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 18 | Edgemond JamesCFO AND TREASURER | UTHRUNITED THERAPEUTICS Corp Open-market sale · 10b5-1 plan | SELL | $1.13M 1,956 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 17 | McCallion Kevin J.SVP, Products and Production |  MASS908 Devices Inc.Open-market sale · 10b5-1 plan | SELL | $131K 18.6K sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Van Well DaanChief Legal Officer |  SOPHSOPHiA GENETICS SAOpen-market sale · 10b5-1 plan | SELL | $9,424 1,988 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Slowe Christopher BrianChief Technology Officer |  RDDTReddit, Inc.Open-market sale · 10b5-1 plan | SELL | $1.25M 8,100 sh | Apr 10, 2026 traded Apr 8, 2026 |
| 16 | Menu PhilippeChief Medical Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $9,152 1,931 sh | Apr 10, 2026 traded Apr 9, 2026 |
| 16 | Menu PhilippeChief Medical Officer | SOPHSOPHiA GENETICS SA Open-market sale · 10b5-1 plan | SELL | $14K 2,800 sh | Apr 10, 2026 traded Apr 8, 2026 |